|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1995-4-13
|
|
pubmed:abstractText |
The capability of chronic tricyclic antidepressant drug (TAD) treatment to elicit myocardial damage has been a subject of debate. Lack of an adequate noninvasive method to detect such damage has prevented an in-depth study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1619-23
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:7882465-Adult,
pubmed-meshheading:7882465-Antibodies, Monoclonal,
pubmed-meshheading:7882465-Antidepressive Agents, Tricyclic,
pubmed-meshheading:7882465-Cardiomyopathies,
pubmed-meshheading:7882465-Depressive Disorder,
pubmed-meshheading:7882465-Female,
pubmed-meshheading:7882465-Humans,
pubmed-meshheading:7882465-Indium Radioisotopes,
pubmed-meshheading:7882465-Male,
pubmed-meshheading:7882465-Myosins
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment.
|
|
pubmed:affiliation |
Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
